Contact this trialFirst, we need to learn more about you.
Placebo +1 More for Coronavirus
Recruiting2 awardsPhase 3
Honolulu, Hawaii
This trial will compare the effects of tocilizumab versus placebo in 300 adults hospitalized with severe COVID-19. Tocilizumab is given as an IV infusion, and the dose may be repeated if symptoms worsen. Participants will be followed for 28 days.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.